📊 Score Breakdown
Offering Ability
20
Cash Runway
95
Float Risk
40
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
⛈️
Warning
High probability of dilution event
61%
🔄 Reverse Split
70%
• 50-day avg $0.06 below $1 exchange minimum
• Only 0 months cash — financial pressure
💰 Capital Raise
55%
• Critical: only 0.3 months cash remaining
📉 Score Deterioration
50%
• Score rose 41 points recently (worsening)
• Score in HIGH risk zone (65/100)
💹 Market Data
Market Cap$102.2K
Shares Outstanding3.10M
FloatN/A
Cash$1.06M
Debt$2.93M
Short InterestN/A
🏛 Institutional Holdings
Institutional data not yet available.
📉 Short Interest
Short Interest121.6K
Days to Cover11.5
% of FloatN/A
FINRA data as of May 15, 2026
📁 Recent SEC Activity
No recent SEC insights
📰 Recent News
No recent news
🔬 More Research for BHATF
📊 BHATF FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 BHATF Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.